Literature DB >> 8479418

Fetal alcohol syndrome--United States, 1979-1992.

.   

Abstract

Fetal alcohol syndrome (FAS) is characterized by a variety of physical and behavioral traits that result from maternal alcohol consumption during pregnancy. Features of FAS include prenatal or postnatal growth deficiency, abnormal facial features, and central nervous system deficits. CDC's Birth Defects Monitoring Program (BDMP)--a national program to monitor congenital malformations--has collected data on the incidence of FAS among newborn infants since 1979. This report presents a rate for FAS in the United States using BDMP data from 1979 through 1992.

Entities:  

Mesh:

Year:  1993        PMID: 8479418

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  3 in total

Review 1.  Fetal alcohol spectrum disorders: an overview.

Authors:  Edward P Riley; M Alejandra Infante; Kenneth R Warren
Journal:  Neuropsychol Rev       Date:  2011-04-16       Impact factor: 7.444

2.  Estimating the community prevalence, child traits, and maternal risk factors of fetal alcohol spectrum disorders (FASD) from a random sample of school children.

Authors:  Philip A May; Julie M Hasken; Stephen R Hooper; Dixie M Hedrick; Julia Jackson-Newsom; Chalise E Mullis; Elizabeth Dobyns; Wendy O Kalberg; David Buckley; Luther K Robinson; Omar Abdul-Rahman; Margaret P Adam; Melanie A Manning; Tamison Jewett; H Eugene Hoyme
Journal:  Drug Alcohol Depend       Date:  2021-08-02       Impact factor: 4.852

3.  Methods for surveillance of fetal alcohol syndrome: The Fetal Alcohol Syndrome Surveillance Network II (FASSNetII) - Arizona, Colorado, New York, 2009 - 2014.

Authors:  Leslie A O'Leary; Linnette Ortiz; April Montgomery; Deborah J Fox; Christopher Cunniff; Margaret Ruttenber; April Breen; Sydney Pettygrove; Don Klumb; Charlotte Druschel; Jaime L Frías; Luther K Robinson; Jacquelyn Bertrand; Kelly Ferrara; Maureen Kelly; Suzanne M Gilboa; F John Meaney
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2015-03-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.